Ziprasidone in the treatment of Parkinson's disease psychosis

Eur Psychiatry. 2006 Dec;21(8):578-9. doi: 10.1016/j.eurpsy.2005.05.005. Epub 2005 Aug 31.

Authors

I-Shin Shiah¹, Chun-Lung Lin, Wei-Chung Mao, Sy-Ueng Luu

Affiliation

¹ Department of Psychiatry, Tri-Service General Hospital, No. 325, Sec. 2, Cheng-Gung Road, Neihu District, Taipei 114, Taiwan, ROC. ishiah@ms45.hinet.net

PMID: 16139485
DOI: 10.1016/j.eurpsy.2005.05.005

No abstract available

Publication types

Case Reports

MeSH terms

Antipsychotic Agents / adverse effects
Antipsychotic Agents / therapeutic use*
Dose-Response Relationship, Drug
Humans
Male
Middle Aged
Motor Activity / drug effects
Parkinson Disease / complications*
Parkinson Disease / psychology
Piperazines / adverse effects
Piperazines / therapeutic use*
Psychotic Disorders / complications*
Psychotic Disorders / drug therapy*
Psychotic Disorders / psychology
Taiwan
Thiazoles / adverse effects
Thiazoles / therapeutic use*
Treatment Outcome

Substances

Antipsychotic Agents
Piperazines
Thiazoles
ziprasidone